Oncological outcomes of sequential laparoscopic gastrectomy after treatment with camrelizumab combined with nab-paclitaxel plus S-1 for gastric cancer with serosal invasion

Oncological outcomes of sequential laparoscopic gastrectomy after treatment with camrelizumab combined with nab-paclitaxel plus S-1 for gastric cancer with serosal invasion

ObjectiveTo explore the oncological outcomes of sequential laparoscopic gastrectomy after treatment with camrelizumab in combination with nab-paclitaxel plus S-1 for the treatment of gastric cancer with serosal invasion.MethodsThis study is a retrospective cohort study and retrospectively analyzed t...

Full description

Bibliographic Details
Main Authors: Ju-Li Lin, Mi Lin, Guang-Tan Lin, Qing Zhong, Jun Lu, Chao-Hui Zheng, Jian-Wei Xie, Jia-bin Wang, Chang-Ming Huang, Ping Li
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-01-01
Series:Frontiers in Immunology
Subjects:
Gastric cancer with serous invasion
Camrelizumab
Neoadjuvant chemotherapy
2-years overall survival rate
2-year recurrence free survival rate
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2024.1322152/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2024.1322152/full

Similar Items